Sector consensus MedinCell S.A.

Equities

Real-time Euronext Paris Other stock markets 08:58:22 2025-02-11 am EST			5-day change	1st Jan Change
15.28 ^EUR	+1.73%		-4.51%	-8.18%

Feb. 10	Medincell: a milestone payment from Teva	CF
Feb. 10	Medincell: a milestone payment from Teva	CF

Sector:

Location:

X axis:

Main competitors

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Ecart obj. / dr	Nbr of analysts
MEDINCELL S.A.	€23.17	+54.24%	6
ELI LILLY AND COMPANY	$979.86	+12.77%	26
NOVO NORDISK A/S	DKK 828.42	+34.61%	24
JOHNSON & JOHNSON	$168.64	+9.34%	21
ABBVIE INC.	$204.9	+7.65%	27
ROCHE HOLDING AG	CHF 307.34	+5.76%	19
ASTRAZENECA PLC	GBX 173.65	+19.63%	19
NOVARTIS AG	CHF 114.68	+7.71%	20
AMGEN INC.	$316.7	+7.43%	26
PFIZER, INC.	$31.04	+19.98%	22
SANOFI	€116.62	+12.35%	22
GILEAD SCIENCES, INC.	$101.24	+6.03%	25
BRISTOL-MYERS SQUIBB COMPANY	$61.24	+10.29%	21
CHUGAI PHARMACEUTICAL CO., LTD	¥7,510	+7.59%	15
GSK PLC	GBX 18.04	+23.13%	19
DAIICHI SANKYO CO., LTD.	¥6,216.67	+66.85%	18
HALEON PLC	GBX 3.993	+3.12%	17
TAKEDA PHARMACEUTICAL COMPANY LIMITED	¥4,777.35	+16.35%	17
JIANGSU HENGRUI MEDICINE CO., LTD.	CN¥59.81	+33.26%	16
Average	1,158.6	+18.85%	20
Weighted average by Cap.	705.88	+14.58%	23